N. Wesley Norton

Clinical Pharmacokinetics, Safety, and Tolerability of a Novel, First-in-Class TRPV4 Ion Channel Inhibitor, GSK2798745, in Healthy and Heart Failure Subjects

Navin Goyal, Peter J. Skrdla, Rosemary Schroyer et al. · American Journal of Cardiovascular Drugs · 2019 · 147 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +15

EFFICACY OF THE β3-ADRENERGIC RECEPTOR AGONIST CL-316243 ON EXPERIMENTAL BLADDER HYPERREFLEXIA AND DETRUSOR INSTABILITY IN THE RAT

Morgan Woods, Nancyleigh Carson, N. Wesley Norton et al. · The Journal of Urology · 2001 · 112 citations

Medicine, Pharmacology, Urology +11

Design and SAR of Novel Potassium Channel Openers Targeted for Urge Urinary Incontinence. 1. <i>N</i>-Cyanoguanidine Bioisosteres Possessing in Vivo Bladder Selectivity

John A. Butera, Madelene Antane, Schuyler Antane et al. · Journal of Medicinal Chemistry · 2000 · 79 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

Synthesis and potassium channel opening activity of substituted 10H-Benzofuro[3,2-b]indole- and 5,10-Dihydro-indeno[1,2-b]indole-1-carboxylic acids

John A. Butera, Schuyler Antane, Bradford Hirth et al. · Bioorganic & Medicinal Chemistry Letters · 2001 · 73 citations

Natural Sciences, Medicinal Chemistry, Pharmacology +12

Design and SAR of Novel Potassium Channel Openers Targeted for Urge Urinary Incontinence. 2. Selective and Potent Benzylamino Cyclobutenediones

A. Gilbert, Madelene Antane, Thomas M. Argentieri et al. · Journal of Medicinal Chemistry · 2000 · 53 citations

Medicine, Medicinal Chemistry, Pharmacology +15